Insilico PandaOmics - Software for OMICs Data Analysis
From Pharma.AI
A roadmap to successful disease research and target identification strategies requires considerable resources spent on search, collection and interpretation of data during several months of work. PandaOmics provides a unique opportunity to both explore the unknown of OMICs data and interpret it in the context of all the scientific data generated by the scientific community.
-
Most popular related searches
Zero Bioinformatics Experience Is Required
PandaOmics for Research
OMICs data analysis
Access the full set of OMICs data generated by the scientific community so far. You do not need to spend your time trying to convert your data into an interpretable format or wait for a bioinformatician to do that for you — instead, you will find all the data already processed and uploaded in a uniform way, so you can focus on science and data interpretation.
Comprehensive pathway analysis
Pathway analysis is a crucial step toward a complete understanding of how data works. It converts a list of seemingly unrelated genes into a connected story based on dysregulated molecular processes. PandaOmics uses a proprietary pathway analysis approach called iPanda to infer pathway activation or inhibition. Results published in Nature communications in 2016 demonstrated the algorithm outperforming other pathway analysis tools.
Actionable Target Identification
Once you have brought the context of related OMICs to your disease, start exploring the set of actionable drug target hypotheses that PandaOmics provides. A set of artificial intelligence algorithms analyzes the whole pool of text data, mentioning all significant genes from your experiment in the context of the disease you are studying, and brings both clear and hidden connections from the dataset and publications, grants, patents, clinical trials, etc.
5M OMICs data samples
A full spectrum of transcriptomics, genomics, epigenomics, proteomics, single cell data generated by the scientific community
1.3M Compound & Biologics
Drugs from Phase 1 of clinical trial till Launched phase
3M Grants
Life sciences research grant funding
3.8M Patents
Patents covering the life sciences industry
342K Clinical Trials
Explore extra knowledge related to the clinical trials design
30M Publications
Published biomedical research results
PandaOmics for Target ID
Discover both molecular and text evidence connecting a target to a disease.
Chemistry42 is a fully automated artificial intelligence platform that does everything for you in a week
Customer reviews
No reviews were found for Insilico PandaOmics - Software for OMICs Data Analysis. Be the first to review!